125 related articles for article (PubMed ID: 4754791)
1. Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules.
Ilett KF; Reid WD; Sipes IG; Krishna G
Exp Mol Pathol; 1973 Oct; 19(2):215-29. PubMed ID: 4754791
[No Abstract] [Full Text] [Related]
2. Mechanism of renal necrosis induced by bromobenzene or chlorobenzene.
Reid WD
Exp Mol Pathol; 1973 Oct; 19(2):197-214. PubMed ID: 4754790
[No Abstract] [Full Text] [Related]
3. Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice.
Lettéron P; Degott C; Labbe G; Larrey D; Descatoire V; Tinel M; Pessayre D
Toxicol Appl Pharmacol; 1987 Nov; 91(2):266-73. PubMed ID: 3118512
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of chloroform nephrotoxicity. IV. Phenobarbital potentiation of in vitro chloroform metabolism and toxicity in rabbit kidneys.
Bailie MB; Smith JH; Newton JF; Hook JB
Toxicol Appl Pharmacol; 1984 Jun; 74(2):285-92. PubMed ID: 6740677
[TBL] [Abstract][Full Text] [Related]
5. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.
Jollow DJ; Mitchell JR; Potter WZ; Davis DC; Gillette JR; Brodie BB
J Pharmacol Exp Ther; 1973 Oct; 187(1):195-202. PubMed ID: 4746327
[No Abstract] [Full Text] [Related]
6. Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice.
Smith JH; Hook JB
Toxicol Appl Pharmacol; 1984 May; 73(3):511-24. PubMed ID: 6719466
[TBL] [Abstract][Full Text] [Related]
7. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
[TBL] [Abstract][Full Text] [Related]
8. Effects of differential changes in rat hepatic and renal cytochrome P-450 concentrations on hepatotoxicity and nephrotoxicity of chloroform.
McMartin DN; O'Connor JA; Kaminsky LS
Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):99-110. PubMed ID: 7255876
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies on the metabolism and covalent binding of [14C]1,1-dichloroethylene by mouse liver, kidney and lung.
Okine LK; Gram TE
Biochem Pharmacol; 1986 Aug; 35(16):2789-95. PubMed ID: 3741469
[TBL] [Abstract][Full Text] [Related]
10. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro.
Potter WZ; Davis DC; Mitchell JR; Jollow DJ; Gillette JR; Brodie BB
J Pharmacol Exp Ther; 1973 Oct; 187(1):203-10. PubMed ID: 4147720
[No Abstract] [Full Text] [Related]
11. Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsomal enzyme inhibitor piperonyl butoxide.
Kluwe WM; Hook JB
Toxicol Appl Pharmacol; 1981 Jul; 59(3):457-66. PubMed ID: 7268770
[No Abstract] [Full Text] [Related]
12. [Formation of chloroform from carbon tetrachloride in liver microsomes, lipid peroxidation and destruction of cytochrome P-450].
Reiner O; Athanassopoulos S; Hellmer KH; Murray RE; Uehleke H
Arch Toxikol; 1972; 29(3):219-33. PubMed ID: 4404917
[No Abstract] [Full Text] [Related]
13. Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters.
Potter WZ; Thorgeirsson SS; Jollow DJ; Mitchell JR
Pharmacology; 1974; 12(3):129-43. PubMed ID: 4445191
[No Abstract] [Full Text] [Related]
14. Time dependence of chloroform-induced metabolic alterations in the liver and kidney of B6C3F1 mice.
Rossi S; Gemma S; Fabrizi L; Testai E; Vittozzi L
Arch Toxicol; 1999 Sep; 73(7):387-93. PubMed ID: 10550481
[TBL] [Abstract][Full Text] [Related]
15. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
Boyd MR; Dutcher JS
J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642
[TBL] [Abstract][Full Text] [Related]
16. In vivo studies on the relationship between hepatic metabolism and the renal toxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
Kramer RA; McMenamin MG; Boyd MR
Toxicol Appl Pharmacol; 1986 Sep; 85(2):221-30. PubMed ID: 3764909
[TBL] [Abstract][Full Text] [Related]
17. The effect of mixed function oxidase induction and inhibition on salicylate-induced nephrotoxicity in male rats.
Kyle ME; Kocsis JJ
Toxicol Appl Pharmacol; 1986 Jun; 84(2):241-9. PubMed ID: 3715872
[TBL] [Abstract][Full Text] [Related]
18. In vitro covalent binding of cismethrin, bioresmethrin, and their common alcohol to hepatic proteins.
Hoellinger H; Sonnier M; Gray AJ; Connors TA; Pichon J; Nguyen HN
Toxicol Appl Pharmacol; 1985 Jan; 77(1):11-8. PubMed ID: 3966234
[TBL] [Abstract][Full Text] [Related]
19. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.
Buckpitt AR; Warren DL
J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280
[TBL] [Abstract][Full Text] [Related]
20. Effect of drugs which alter microsomal drug-metabolizing enzyme activity on rat hepatic cholesterol biosynthesis.
Abernethy DR; Azarnoff DL
Biochem Pharmacol; 1977 Mar; 26(6):481-4. PubMed ID: 849344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
